Contact

All Stories

  1. Design and development of inhalable cefepime dry powder targeting P. aeruginosa infections

    Article • European Journal of Pharmaceutics and Biopharmaceutics, October 2026, Elsevier

    Dr Daniel Pletzer

  2. Proteomic profiling of the Pseudomonas aeruginosa stringent response highlights global adaptive responses during stationary phase

    Article • mSystems, September 2026, ASM Journals

    Dr Daniel Pletzer

  3. Antibiofilm Peptides Revisited: From Biofilm Models and Metrics to Mechanisms and Translation

    Article • ACS Infectious Diseases, August 2026, American Chemical Society (ACS)

    Dr Daniel Pletzer

  4. Detection of Antibiotic‐Resistant Campylobacter on Retail Chicken in New Zealand: A Sentinel Survey

    Article • Journal of the Royal Society of New Zealand, July 2026, Wiley

    Dr Daniel Pletzer

  5. Targeting the stringent response alters gene expression and extracellular vesicle RNA in Staphylococcus aureus

    Article • Microbiology Spectrum, July 2026, ASM Journals

    Dr Daniel Pletzer

  6. Recent advances in gold and zinc oxide nanoparticles: Antibiofilm action, mechanisms beyond ROS generation, and in vivo efficacy

    Article • Microbiological Research, May 2026, Elsevier

    Dr Daniel Pletzer

  7. Protocol for a murine skin abscess model to study bacterial infection dynamics, microbial interactions, and treatment efficacy

    Article • STAR Protocols, March 2026, Elsevier

    Dr Daniel Pletzer

  8. Inhaled Antibiotic and Biologic Formulations Targeting Pseudomonas aeruginosa

    Article • Pharmaceutics, January 2026, MDPI AG

    Dr Daniel Pletzer

  9. Advanced antimicrobial peptide-based biomaterials for food safety applications

    Article • LWT, January 2026, Elsevier

    Dr Daniel Pletzer

  10. Host-inspired anti-virulence strategies against membrane-targeting bacterial toxins: modification and mimicry

    Article • Critical Reviews in Microbiology, December 2025, Taylor & Francis

    Dr Daniel Pletzer

  11. Cell-Derived Nanocarriers of Apoptotic Bodies with an Antimicrobial Peptide for Targeting Intracellular S. aureus Infections

    Article • ACS Applied Bio Materials, October 2025, American Chemical Society (ACS)

    Dr Daniel Pletzer

  12. Intranasal phage therapy overcomes antibody neutralization challenges in pulmonary Pseudomonas aeruginosa infections

    Article • Archives of Microbiology, October 2025, Springer Science + Business Media

    Dr Daniel Pletzer

  13. Antiparasitic effect of peptoids against Cryptosporidium parvum

    Article • Microbiology, October 2025, Society for General Microbiology

    Dr Daniel Pletzer

  14. A review of recently discovered mechanisms of cephalosporin resistance in Pseudomonas aeruginosa

    Article • International Journal of Antimicrobial Agents, August 2025, Elsevier

    Dr Daniel Pletzer

  15. Synthetic host defense peptide inhibits SARS-CoV-2 replication in vitro

    Article • Antimicrobial Agents and Chemotherapy, June 2025, ASM Journals

    Dr Daniel Pletzer, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  16. Targeting biofilms with novel peptides

    Article • Biofilm, June 2025, Elsevier

    Dr Daniel Pletzer

  17. Azithromycin represses evolution of ceftazidime/avibactam resistance by translational repression of rpoS in Pseudomonas aeruginosa

    Article • Journal of Bacteriology, May 2025, ASM Journals

    Dr Daniel Pletzer

  18. Comparative lipidomics profiles of planktonic and biofilms of methicillin-resistant and -susceptible Staphylococcus aureus

    Article • Analytical Biochemistry, March 2025, Elsevier

    Dr Daniel Pletzer

  19. Editorial: Reviews in microbial pathogenesis

    Article • Frontiers in Microbiology, February 2025, Frontiers

    Dr Daniel Pletzer

  20. DJK-5, an anti-biofilm peptide, increases Staphylococcus aureus sensitivity to colistin killing in co-biofilms with Pseudomonas aeruginosa

    Article • npj Biofilms and Microbiomes, January 2025, Springer Science + Business Media

    Dr Daniel Pletzer

  21. Pressure injuries and biofilms: Microbiome, model systems and therapies

    Article • Wound Repair and Regeneration, January 2025, Wiley

    Dr Daniel Pletzer

  22. Gold nanoparticles as innovative therapeutics for oral mucositis: A review of current evidence

    Article • Drug Delivery and Translational Research, December 2024, Springer Science + Business Media

    Dr Daniel Pletzer

  23. Phage cocktail amikacin combination as a potential therapy for bacteremia associated with carbapenemase producing colistin resistant Klebsiella pneumoniae

    Article • Scientific Reports, November 2024, Springer Science + Business Media

    Dr Daniel Pletzer

  24. Allenamides as a Powerful Tool to Incorporate Diversity: Thia‐Michael Lipidation of Semisynthetic Peptides and Access to β‐Keto Amides

    Article • Angewandte Chemie, August 2024, Wiley

    Dr Daniel Pletzer

  25. Allenamides as a Powerful Tool to Incorporate Diversity: Thia‐Michael Lipidation of Semisynthetic Peptides and Access to β‐Keto Amides

    Article • Angewandte Chemie, August 2024, Wiley

    Dr Daniel Pletzer

  26. From Data to Decisions: Leveraging Artificial Intelligence and Machine Learning in Combating Antimicrobial Resistance – a Comprehensive Review

    Article • Journal of Medical Systems, August 2024, Springer Science + Business Media

    Dr Daniel Pletzer

  27. Antiparasitic effect of peptoids againstCryptosporidium parvum

    Article • July 2024, Cold Spring Harbor Laboratory Press

    Dr Daniel Pletzer

  28. Current and novel therapies for management of Acinetobacter baumannii -associated pneumonia

    Article • Critical Reviews in Microbiology, July 2024, Taylor & Francis

    Dr Daniel Pletzer

  29. Site-Specific Antimicrobial Activity of a Dual-Responsive Ciprofloxacin Prodrug

    Article • Journal of Medicinal Chemistry, May 2024, American Chemical Society (ACS)

    Dr Daniel Pletzer

  30. Using host-mimicking conditions and a murine cutaneous abscess model to identify synergistic antibiotic combinations effective against Pseudomonas aeruginosa

    Article • Frontiers in Cellular and Infection Microbiology, May 2024, Frontiers

    Dr Daniel Pletzer

  31. Biodistribution of Native and Nanoformulated Innate Defense Regulator Peptide 1002

    Article • Molecular Pharmaceutics, May 2024, American Chemical Society (ACS)

    Dr Daniel Pletzer

  32. Murepavadin promotes the killing efficacies of aminoglycoside antibiotics against Pseudomonas aeruginosa by enhancing membrane potential

    Article • Antimicrobial Agents and Chemotherapy, April 2024, ASM Journals

    Dr Daniel Pletzer

  33. Repurposing ebselen as an inhalable dry powder to treat respiratory tract infections

    Article • European Journal of Pharmaceutics and Biopharmaceutics, February 2024, Elsevier

    Dr Daniel Pletzer, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  34. Effectiveness of gold nanoparticles in prevention and treatment of oral mucositis in animal models: a systematic review

    Article • Systematic Reviews, January 2024, Springer Science + Business Media

    Dr Daniel Pletzer

  35. Size-Controlled Synthesis of Gold Nanoparticles Tethering Antimicrobial Peptides with Potent Broad-Spectrum Antimicrobial and Antibiofilm Activities

    Article • Molecular Pharmaceutics, January 2024, American Chemical Society (ACS)

    Dr Daniel Pletzer

  36. Novel intranasal phage-CaEDTA-ceftazidime/avibactam triple combination therapy demonstrates remarkable efficacy in treating Pseudomonas aeruginosa lung infection

    Article • Biomedicine & Pharmacotherapy, December 2023, Elsevier

    Dr Daniel Pletzer

  37. Murepavadin induces envelope stress response and enhances the killing efficacies of β-lactam antibiotics by impairing the outer membrane integrity of Pseudomonas aeruginosa

    Article • Microbiology Spectrum, October 2023, ASM Journals

    Dr Daniel Pletzer

  38. Surviving the host: Microbial metabolic genes required for growth of Pseudomonas aeruginosa in physiologically-relevant conditions

    Article • Frontiers in Microbiology, November 2022, Frontiers

    Dr Daniel Pletzer

  39. The ColR/S two-component system is a conserved determinant of host association across Pseudomonas species

    Article • The ISME Journal, November 2022, Springer Science + Business Media

    Dr Daniel Pletzer

  40. Inhalable ceftazidime-roflumilast powder targeting infection and inflammation: Influence of incorporating roflumilast into ceftazidime-leucine co-amorphous formulation

    Article • European Journal of Pharmaceutics and Biopharmaceutics, November 2022, Elsevier

    Dr Daniel Pletzer

  41. Three-Dimensional Printed Cellulose for Wound Dressing Applications

    Article • 3D Printing and Additive Manufacturing, October 2022, Mary Ann Liebert Inc

    Dr Daniel Pletzer

  42. Biodistribution and toxicity of innate defense regulator 1018 (IDR-1018)

    Article • European Journal of Pharmaceutics and Biopharmaceutics, October 2022, Elsevier

    Dr Daniel Pletzer

  43. Targeting the Pseudomonas aeruginosa Virulence Factor Phospholipase C With Engineered Liposomes

    Article • Frontiers in Microbiology, March 2022, Frontiers

    Dr Daniel Pletzer

  44. Self-Assembly of Antimicrobial Peptoids Impacts Their Biological Effects on ESKAPE Bacterial Pathogens

    Article • ACS Infectious Diseases, February 2022, American Chemical Society (ACS)

    Dr Daniel Pletzer

  45. Antibiofilm and immunomodulatory resorbable nanofibrous filing for dental pulp regenerative procedures

    Article • Bioactive Materials, February 2022, Elsevier

    Dr Daniel Pletzer

  46. Ultraviolet-C Irradiation, Heat, and Storage as Potential Methods of Inactivating SARS-CoV-2 and Bacterial Pathogens on Filtering Facepiece Respirators

    Article • Pathogens, January 2022, MDPI AG

    Dr Daniel Pletzer, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  47. 3D printed cellulose based product applications

    Article • Materials Chemistry Frontiers, January 2022, Royal Society of Chemistry

    Dr Daniel Pletzer

  48. Cellulose composites containing active constituents of coffee and tea: a prospective novel wound dressing

    Article • Materials Advances, January 2022, Royal Society of Chemistry

    Dr Daniel Pletzer

  49. The ColR/S two-component system is a conserved determinant of host association across Pseudomonas species

    Article • December 2021, Cold Spring Harbor Laboratory Press

    Dr Daniel Pletzer

  50. Enzymatically releasable polyethylene glycol – host defense peptide conjugates with improved activity and biocompatibility

    Article • Journal of Controlled Release, November 2021, Elsevier

    Dr Daniel Pletzer

  51. Synergistic bactericidal activities of tobramycin with ciprofloxacin and azithromycin against Klebsiella pneumoniae

    Article • The Journal of Antibiotics, May 2021, Springer Science + Business Media

    Dr Daniel Pletzer

  52. Peptide 1018 inhibits swarming and influences Anr-regulated gene expression downstream of the stringent stress response in Pseudomonas aeruginosa

    Article • PLOS One, April 2021, PLOS

    Dr Daniel Pletzer, Dr Robert E Hancock

  53. Treatment with a neutrophil elastase inhibitor and ofloxacin reduces P. aeruginosa burden in a mouse model of chronic suppurative otitis media

    Article • npj Biofilms and Microbiomes, April 2021, Springer Science + Business Media

    Dr Daniel Pletzer

  54. Murine Model of Sinusitis Infection for Screening Antimicrobial and Immunomodulatory Therapies

    Article • Frontiers in Cellular and Infection Microbiology, March 2021, Frontiers

    Dr Daniel Pletzer

  55. Friends or enemies? The complicated relationship between Pseudomonas aeruginosa and Staphylococcus aureus

    Article • Molecular Microbiology, March 2021, Wiley

    Dr Daniel Pletzer

  56. Human organoid biofilm model for assessing antibiofilm activity of novel agents

    Article • npj Biofilms and Microbiomes, January 2021, Springer Science + Business Media

    Dr Daniel Pletzer

  57. Towards understanding single-channel characteristics of OccK8 purified from Pseudomonas aeruginosa

    Article • European Biophysics Journal, January 2021, Springer Science + Business Media

    Dr Daniel Pletzer

  58. Rapid microwave-based method for the preparation of antimicrobial lignin-capped silver nanoparticles active against multidrug-resistant bacteria

    Article • International Journal of Pharmaceutics, January 2021, Elsevier

    Dr Daniel Pletzer

  59. Contribution of swarming motility to dissemination in a Pseudomonas aeruginosa murine skin abscess infection model

    Article • The Journal of Infectious Diseases, December 2020, Oxford University Press (OUP)

    Dr Daniel Pletzer

  60. Identification of novel targets of azithromycin activity against Pseudomonas aeruginosa grown in physiologically relevant media

    Article • Proceedings of the National Academy of Sciences, December 2020, Proceedings of the National Academy of Sciences

    Dr Robert E Hancock, Dr Daniel Pletzer

  61. Host Defense Peptide-Mimicking Amphiphilic β-Peptide Polymer (Bu:DM) Exhibiting Anti-Biofilm, Immunomodulatory, and in Vivo Anti-Infective Activity

    Article • Journal of Medicinal Chemistry, October 2020, American Chemical Society (ACS)

    Dr Daniel Pletzer

  62. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections

    Article • mBio, September 2020, ASM Journals

    Dr Daniel Pletzer

  63. A cyclic derivative of host-defence peptide IDR-1018 improves proteolytic stability, suppresses inflammation, and enhances in vivo activity

    Article • Journal of Medicinal Chemistry, August 2020, American Chemical Society (ACS)

    Dr Daniel Pletzer

  64. The Stringent Stress Response Controls Proteases and Global Regulators under Optimal Growth Conditions in Pseudomonas aeruginosa

    Article • mSystems, August 2020, ASM Journals

    Dr Daniel Pletzer

  65. A novel mouse model of chronic suppurative otitis media and its use in preclinical antibiotic evaluation

    Article • Science Advances, August 2020, American Association for the Advancement of Science

    Dr Daniel Pletzer

  66. The stringent stress response controls proteases and global regulators under optimal growth conditions in Pseudomonas aeruginosa

    Article • May 2020, Cold Spring Harbor Laboratory Press

    Dr Daniel Pletzer

  67. Rough-type and loss of the LPS due to lpx genes deletions are associated with colistin resistance in multidrug-resistant clinical Escherichia coli isolates not harbouring mcr genes

    Article • PLOS One, May 2020, PLOS

    Dr Daniel Pletzer

  68. NtrBC Regulates Invasiveness and Virulence of Pseudomonas aeruginosa During High-Density Infection

    Article • Frontiers in Microbiology, May 2020, Frontiers

    Dr Daniel Pletzer

  69. Mechanistic understanding enables the rational design of salicylanilide combination therapies for Gram-negative infections

    Article • April 2020, Cold Spring Harbor Laboratory Press

    Dr Daniel Pletzer

  70. Surfing motility is a complex adaptation dependent on the stringent stress response in Pseudomonas aeruginosa LESB58

    Article • PLoS Pathogens, March 2020, PLOS

    Dr Daniel Pletzer, Dr Robert E Hancock

  71. Hyaluronic acid-based nanogels improve in vivo compatibility of the anti-biofilm peptide DJK-5

    Article • Nanomedicine Nanotechnology Biology and Medicine, June 2019, Elsevier

    Dr Daniel Pletzer

  72. Dismantling the bacterial virulence program

    Article • Microbial Biotechnology, March 2019, Wiley

    Dr Daniel Pletzer

  73. Controlling biofilm formation with nitroxide functional surfaces

    Article • Polymer Chemistry, January 2019, Royal Society of Chemistry

    Dr Daniel Pletzer, Prof. Dr. Leonie Barner

  74. Aurein-derived antimicrobial peptides formulated with pegylated phospholipid micelles to target methicillin-resistant Staphylococcus aureus skin infections

    Article • ACS Infectious Diseases, December 2018, American Chemical Society (ACS)

    Dr Daniel Pletzer

  75. Is synergy the key to treating high-density infections?

    Article • Future Microbiology, November 2018, Future Medicine

    Dr Daniel Pletzer

  76. Synergy between conventional antibiotics and anti-biofilm peptides in a murine, sub-cutaneous abscess model caused by recalcitrant ESKAPE pathogens

    Article • PLoS Pathogens, June 2018, PLOS

    Dr Daniel Pletzer

  77. Liposomal Therapy Attenuates Dermonecrosis Induced by Community-Associated Methicillin-Resistant Staphylococcus aureus by Targeting α-Type Phenol-Soluble Modulins and α-Hemolysin

    Article • EBioMedicine, June 2018, Elsevier

    Dr Daniel Pletzer

  78. Helicobacter pylori Biofilm Formation Is Differentially Affected by Common Culture Conditions, and Proteins Play a Central Role in the Biofilm Matrix

    Article • Applied and Environmental Microbiology, May 2018, ASM Journals

    Dr Daniel Pletzer, Dr D. Scott Merrell

  79. TonB-Dependent Receptor Repertoire of Pseudomonas aeruginosa for Uptake of Siderophore-Drug Conjugates

    Article • Antimicrobial Agents and Chemotherapy, March 2018, ASM Journals

    Dr Daniel Pletzer

  80. Impact of Host Defense Peptides on Chronic Wounds and Infections

    Article • January 2018, Springer Science + Business Media

    Dr Daniel Pletzer

  81. New Perspectives in Biofilm Eradication

    Article • ACS Infectious Diseases, December 2017, American Chemical Society (ACS)

    Dr Daniel Pletzer

  82. Alternative strategies to fight drug resistant bacteria in an abscess infection model

    Article • Frontiers in Microbiology, September 2017, Frontiers

    Dr Daniel Pletzer

  83. Alternative strategies for the study and treatment of clinical bacterial biofilms

    Article • Emerging Topics in Life Sciences, April 2017, Portland Press Ltd.

    Dr Daniel Pletzer

  84. A Single Residue Acts as Gate in OccK Channels

    Article • The Journal of Physical Chemistry B, March 2017, American Chemical Society (ACS)

    Dr Daniel Pletzer

  85. New Mouse Model for Chronic Infections by Gram-Negative Bacteria Enabling the Study of Anti-Infective Efficacy and Host-Microbe Interactions

    Article • mBio, February 2017, ASM Journals

    Dr Robert E Hancock, Dr Daniel Pletzer

  86. Structure and Function of the PiuA and PirA Siderophore-Drug Receptors from Pseudomonas aeruginosa and Acinetobacter baumannii

    Article • Antimicrobial Agents and Chemotherapy, January 2017, ASM Journals

    Dr Daniel Pletzer

  87. Mechanisms of intrinsic resistance and acquired susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients to temocillin, a revived antibiotic

    Article • Scientific Reports, January 2017, Nature

    Dr Daniel Pletzer

  88. The bacteriophage‐derived transcriptional regulator, LscR, activates the expression of levansucrase genes in Pseudomonas syringae

    Article • Molecular Microbiology, October 2016, Wiley

    Dr Daniel Pletzer

  89. Anti-biofilm peptides as a new weapon in antimicrobial warfare

    Article • Current Opinion in Microbiology, October 2016, Elsevier

    Dr Daniel Pletzer

  90. Bacterial Abscess Formation Is Controlled by the Stringent Stress Response and Can Be Targeted Therapeutically

    Article • EBioMedicine, October 2016, Elsevier

    Dr Daniel Pletzer

  91. Draft Genome Sequence of Dietzia maris DSM 43672, a Gram-Positive Bacterium of the Mycolata Group

    Article • Genome Announcements, June 2016, ASM Journals

    Dr Daniel Pletzer, Miguel Vinas

  92. Antibiofilm Peptides: Potential as Broad-Spectrum Agents

    Article • Journal of Bacteriology, April 2016, ASM Journals

    Dr Robert E Hancock, Dr Daniel Pletzer

  93. Swarming motility is modulated by expression of the putative xenosiderophore transporter SppR-SppABCD in Pseudomonas aeruginosa PA14

    Article • Antonie van Leeuwenhoek, March 2016, Springer Science + Business Media

    Dr Daniel Pletzer

  94. Marinobacter adhaerens HP15 harbors two CzcCBA efflux pumps involved in zinc detoxification

    Article • Antonie van Leeuwenhoek, June 2015, Springer Science + Business Media

    Dr Daniel Pletzer

  95. The Pseudomonas aeruginosa PA14 ABC Transporter NppA1A2BCD Is Required for Uptake of Peptidyl Nucleoside Antibiotics

    Article • Journal of Bacteriology, April 2015, ASM Journals

    Dr Daniel Pletzer

  96. Role of the cell envelope stress regulators BaeR and CpxR in control of RND-type multidrug efflux pumps and transcriptional cross talk with exopolysaccharide synthesis in Erwinia amylovora

    Article • Archives of Microbiology, April 2015, Springer Science + Business Media

    Dr Daniel Pletzer

  97. Expression of extra-cellular levansucrase in Pseudomonas syringae is controlled by the in planta fitness-promoting metabolic repressor HexR

    Article • BMC Microbiology, January 2015, Springer Science + Business Media

    Dr Daniel Pletzer

  98. Identification, characterization, isolation and activity against Escherichia coli of quince (Cydonia oblonga) fruit polyphenols

    Article • Food Research International, November 2014, Elsevier

    Dr Daniel Pletzer

  99. High-Throughput Screening of Dipeptide Utilization Mediated by the ABC Transporter DppBCDF and Its Substrate-Binding Proteins DppA1-A5 in Pseudomonas aeruginosa

    Article • PLOS One, October 2014, PLOS

    Dr Daniel Pletzer

  100. AraC/XylS Family Stress Response Regulators Rob, SoxS, PliA, and OpiA in the Fire Blight Pathogen Erwinia amylovora

    Article • Journal of Bacteriology, June 2014, ASM Journals

    Dr Daniel Pletzer

  101. Characterization and regulation of the Resistance-Nodulation-Cell Division-type multidrug efflux pumps MdtABC and MdtUVW from the fire blight pathogen Erwinia amylovora

    Article • BMC Microbiology, January 2014, Springer Science + Business Media

    Dr Daniel Pletzer

  102. Characterization of AcrD, a Resistance-Nodulation-Cell Division-type multidrug efflux pump from the fire blight pathogen Erwinia amylovora

    Article • BMC Microbiology, January 2014, Springer Science + Business Media

    Dr Daniel Pletzer

  103. Enhanced expression of codon optimized Mycobacterium avium subsp. paratuberculosis antigens in Lactobacillus salivarius

    Article • Frontiers in Cellular and Infection Microbiology, January 2014, Frontiers

    Dr Daniel Pletzer, John Bannantine

  104. The conserved upstream region of lscB/C determines expression of different levansucrase genes in plant pathogen Pseudomonas syringae

    Article • BMC Microbiology, January 2014, Springer Science + Business Media

    Dr Daniel Pletzer

  105. Codon optimisation to improve expression of aMycobacterium aviumssp.paratuberculosis-specific membrane-associated antigen byLactobacillus salivarius

    Article • Pathogens and Disease, April 2013, Oxford University Press (OUP)

    Dr Daniel Pletzer

  106. Phylogenetic detection of horizontal gene transfer during the step-wise genesis of Mycobacterium tuberculosis

    Article • BMC Evolutionary Biology, January 2009, Springer Science + Business Media

    Dr Daniel Pletzer